We are proud to present the 6th episode of our successful All Things Urticaria Podcst Series
In this episode, Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.
Do you have suggestions for future episodes? Please reach out to us via email or fill out this form here and offer your suggestions for future topics and expert selection!
Read more news regarding urticaria
Journal Club,News
April 22, 2024Join us on Thursday, May 2 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! Zhuoran Li (IFA Berlin) will speak about “DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis” [...]
Journal Club
April 19, 2024Join us on Thursday, May 16 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! Nian Liu (IFA Berlin) will speak on “TET2 regulates immune tolerance in chronically activated mast cells” [...]
New centers,News
April 19, 2024On March 26, 2024, we welcomed Servidor Público Estadual de São Paulo Hospital, HSPE-SP Allergy Division in São Paulo, Brazil to the UCARE network. Head: Prof. Fátima Rodrigues Fernandes Deputy: Dr. Maria Elisa [...]
